Zaviye · Coverage map · 2026-10-18 · Trending
Israel's stock exchange concluded a positive week, with Teva Pharmaceuticals seeing gains after an innovative treatment approval. The government also approved a defense procurement budget cut.
The Tel Aviv Stock Exchange concluded a positive week with a strong performance on Friday. Earlier in the week, the index saw a flat trading day with Teva Pharmaceutical Industries standing out. Inflation data for September came in lower than anticipated.
These economic indicators suggest a complex financial landscape. The government's decision to cut funding for defense procurement by NIS 2.6 billion, alongside Teva's positive development with an innovative schizophrenia treatment, points to shifting priorities and sector-specific growth within the Israeli economy.
8 sources across English
Left 0% · Center 100% · Right 0%
Medium factuality (mean credibility of the reporting outlets)Latest report
Covered by language
How outlets framed it
All sources: Globes English reports on various financial and business developments in Israel, including stock market performance, inflation data, pharmaceutical news, corporate acquisitions, and government budget adjustments.
The coverage
8 of the 8 articles behind this story, grouped by where the outlet sits on the spectrum. Links go to the publisher.
Fri: TASE ends positive week strongly Globes - Israel Business News
CPI down by more than expected in September Globes - Israel Business News
Mon: Teva stands out on flat TASE Globes - Israel Business News
Approval for innovative schizophrenia treatment boosts Teva Globes - Israel Business News
US co Proofpoint buying Varonis for $6.3b Globes - Israel Business News
Gov't approves NIS 2.6b cut to fund defense procurement Globes - Israel Business News
Number of cars in Israel doubles in 20 years Globes - Israel Business News
Ayalon eyes CAL acquisition Globes - Israel Business News
Prices war risk and reservist mobilisation faster than any official statement.
